We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

9 hedge funds and large institutions have $231K invested in China Pharma Holdings in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

45% more capital invested

Capital invested by funds: $159K → $231K (+$72K)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

13% more funds holding

Funds holding: 8 → 9 (+1)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$28.5K
2
Jane Street
Jane Street
New York
+$11.8K
3
UBS Group
UBS Group
Switzerland
+$4.51K
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.76K
5
PAM
Panagora Asset Management
Massachusetts
+$1.6K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$12K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.16K

CPHI Hedge Fund Activity: Q4 2018 in Review

9 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2018, worth a combined $231K — up 45% from $159K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CPHI positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $28.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $12K sold.

  • 9 institutional investors held China Pharma Holdings (CPHI) as of Q4 2018, up from 8 in Q3 2018.
  • Funds reported $231K of China Pharma Holdings stock for Q4 2018, up 45% quarter-over-quarter.
  • 4 funds opened new China Pharma Holdings positions in Q4 2018 and 3 closed out, a net change of +1 holder.
  • The largest China Pharma Holdings buyer in Q4 2018 was Virtu Financial, an estimated $28.5K added.
  • The largest China Pharma Holdings seller in Q4 2018 was Citadel Advisors, an estimated $12K sold.

Based on aggregated 13F filings for Q4 2018.